Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

In the original publication, the unit of C-peptide immunoreactivity.
Source: Diabetology International - Category: Endocrinology Source Type: research